Generation of Heparin-induced Thrombocytopenia (HIT)-Antibodies Without Prior Heparin Exposure

NCT01102790 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 160

Last updated 2010-04-15

No results posted yet for this study

Summary

The purpose of this study is to determine the HIT-antibody generation without prior heparin-exposure in patients undergoing orthopedic surgery.

Conditions

Sponsors & Collaborators

  • Johann Wolfgang Goethe University Hospital

    lead OTHER

Principal Investigators

  • Marc Schindewolf, MD · J.W. Goethe University-Hospital Frankfurt/M.

  • Edelgard Lindhoff-Last, Prof. · J.W. Goethe-University Hospital Frankfurt/M.

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-04-30
Primary Completion
2010-09-30
Completion
2010-10-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01102790 on ClinicalTrials.gov